Arcturus Therapeutics Holdings Inc. SEC filings ARCT
Arcturus Therapeutics Holdings Inc. has 416 filings in SEC EDGAR's recent list, going back to Mar 18, 2019. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 5, 2026 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 6, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 14, 2023 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 21, 2022 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 18, 2021 |
| DEF 14A | Proxy statement | Oct 13, 2020 | Nov 10, 2020 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2020 | Oct 2, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 5, 2020 |
| DEF 14A | Proxy statement | Oct 1, 2019 | Oct 25, 2019 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1768224
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.